Details for Patent: 9,220,796

Which drugs does patent 9,220,796 protect, and when does it expire?

Patent 9,220,796 protects OTIPRIO and is included in one NDA.

This patent has ten patent family members in seven countries.

Summary for Patent: 9,220,796

Title:	Sterilization of ciprofloxacin composition
Abstract:	Disclosed herein are methods of making sterilized ciprofloxacin compositions. In some embodiments, the method includes the steps of: (a) forming an aqueous suspension comprising ciprofloxacin particles; (b) heating the aqueous suspension comprising ciprofloxacin particles at a temperature range of from about 100.degree. C. to about 120.degree. C.; and (c) allowing the aqueous suspension comprising ciprofloxacin particles to cool down. Also described herein are otic formulations containing ciprofloxacin formed by the disclosed methods, and therapeutic use of such otic formulation for providing sustained release of ciprofloxacin into the ear for treating various otic disorders and conditions.
Inventor(s):	Coleman; Scott H. (San Diego, CA), Liaw; Wei-Cheng (San Diego, CA), Wroblewski; Jerry (San Mateo, CA), Savel; Robert (San Diego, CA)
Assignee:	OTONOMY, INC. (San Diego, CA)
Application Number:	14/789,771
Patent Claim Types: see list of patent claims	Use; Composition; Formulation;

Drugs Protected by US Patent 9,220,796

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Alk Abello	OTIPRIO	ciprofloxacin	INJECTABLE, SUSPENSION;OTIC	207986-001	Dec 10, 2015		DISCN	Yes	No			Y

International Family Members for US Patent 9,220,796

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2015284048
Australia	2019275578
Australia	2021273549